Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Demyelinating disease: NMO spectrum disorders: clinical or molecular classification?
Emerging subspecialties in neurology: neuroimmunology.
Acceptance of pain in neurological disorders: Associations with functioning and psychosocial well-being.
Effect of interferon beta-1a on B7.1 and B7.2 B-cell expression and its impact on T-cell proliferation.
Management of fatigue in persons with multiple sclerosis.
Heparin-induced thrombocytopenia following plasma exchange in patients with demyelinating neurological disease.
Psychiatric comorbidity in multiple sclerosis: It's not the genes.
Is There A Pulse Wave Encephalopathy Component To Multiple Sclerosis?
Blood cells and endothelial barrier function.
Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9.
Association of Postural Sway with Disability Status and Cerebellar Dysfunction in People with Multiple Sclerosis: A Preliminary Study.
GM-CSF: An immune modulatory cytokine that can suppress autoimmunity.
NQO1 gene rs1800566 variant is not associated with risk for multiple sclerosis.
Rehabilitation interventions for the management of multiple sclerosis relapse: a short scoping review.
Validity and test-retest reliability of a measure of hand sensibility and manual dexterity in people with multiple sclerosis: the ReSense test.
Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain.
Targeting ion channels for the treatment of autoimmune neuroinflammation.
[Interferons and autoimmune diseases].
Apparent Diffusion Coefficient Histograms in the Follow-up of Relapsing-Remitting Multiple Sclerosis.
Interactions of environment and genes in multiple sclerosis.
FTY720 inhibits tumor growth and enhances the tumor-suppressive effect of topotecan in neuroblastoma by interfering with the sphingolipid signaling pathway.
Monitoring technology for wheelchair users with advanced multiple sclerosis.
Effect of fingolimod on cardiac autonomic regulation in patients with multiple sclerosis.
Unusual Presentation of Guillain-Barré Syndrome After Mandibular Fracture Treatment: A Review of the Literature and a New Case.
Association between vestibulo-ocular reflex suppression, balance, gait, and fall risk in ageing and neurodegenerative disease: protocol of a one-year prospective follow-up study.
Pages
« first
‹ previous
…
437
438
439
440
441
442
443
444
445
…
next ›
last »